PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
-4.76%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(+24%)
Cap. Flow
+$260M
Cap. Flow
% of AUM
24.65%
Top 10 Holdings %
Top 10 Hldgs %
61.48%
Holding
30
New
7
Increased
14
Reduced
3
Closed
5
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$39.7M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$39.7M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$38.9M |
| 4 |
argenx
ARGX
|
$34.1M |
| 5 |
Biogen
BIIB
|
$30.8M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$54.3M |
| 2 |
Akero Therapeutics
AKRO
|
$33.1M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$20.9M |
| 4 |
Arvinas
ARVN
|
$20.5M |
| 5 |
Prothena Corp
PRTA
|
$4.52M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $97.2M | 9.21% | 349,593 +110,821 | +46% | +$30.8M |
|
2
Incyte
INCY
$16.5B
| $91.2M | 8.64% | 1,261,711 +408,881 | +48% | +$29.5M |
|
3
Legend Biotech
LEGN
$6.41B
| $72.8M | 6.9% | 1,510,324 +455,454 | +43% | +$22M |
|
|
4
argenx
ARGX
$43.6B
| $67.5M | 6.4% | 181,172 +91,616 | +102% | +$34.1M |
|
|
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
| $57.1M | 5.41% | 281,969 -4,319 | -2% | -$874K |
|
6
Immunocore
IMCR
$1.62B
| $55.7M | 5.28% | 1,126,256 +268,331 | +31% | +$13.3M |
|
7
Arcellx
ACLX
$3.85B
| $54.2M | 5.13% | 1,757,779 +875,678 | +99% | +$27M |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $53.1M | 5.03% | 2,085,698 +334,531 | +19% | +$8.51M |
|
|
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $51.9M | 4.92% | 1,396,779 +128,809 | +10% | +$4.79M |
|
10
Syndax Pharmaceuticals
SNDX
$1.41B
| $48M | 4.55% | 2,274,512 +320,000 | +16% | +$6.76M |
|
11
United Therapeutics
UTHR
$13.8B
| $47.5M | 4.5% | 211,892 +63,000 | +42% | +$14.1M |
|
|
12
Keros Therapeutics
KROS
$618M
| $39.7M | 3.77% | +930,752 | New | +$39.7M |
|
|
ONC
13
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $39.7M | 3.76% | +184,012 | New | +$39.7M |
|
|
CERE
14
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $38.9M | 3.69% | +1,595,199 | New | +$38.9M |
|
|
BCYC
15
Bicycle Therapeutics
BCYC
$511M
| $38.6M | 3.66% | 1,816,781 +583,501 | +47% | +$12.4M |
|
16
Ascendis Pharma
ASND
$11.8B
| $37.6M | 3.57% | 350,866 -1,942 | -0.6% | -$208K |
|
17
Vor Biopharma
VOR
$250M
| $34.9M | 3.3% | 6,477,999 +35,174 | +0.5% | +$189K |
|
18
Zai Lab
ZLAB
$3.68B
| $26M | 2.46% | 780,558 +265,284 | +51% | +$8.82M |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $23.3M | 2.21% | +651,068 | New | +$23.3M |
|
|
VRNA
20
Verona Pharma
VRNA
$9.16B
| $19.3M | 1.83% | +962,361 | New | +$19.3M |
|
21
Crinetics Pharmaceuticals
CRNX
$2.92B
| $18.2M | 1.73% | 1,133,782 +243,677 | +27% | +$3.91M |
|
|
ALPN
22
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $17.9M | 1.7% | 2,317,634 | – | – |
|
|
THRX
23
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $13.4M | 1.27% | +1,505,327 | New | +$13.4M |
|
24
Olema Pharmaceuticals
OLMA
$375M
| $8.27M | 0.78% | +2,382,377 | New | +$8.27M |
|
|
PSTX
25
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.3M | 0.31% | 1,072,410 -1,362,406 | -56% | -$4.2M |
|